6:28 PM
 | 
Jan 15, 2013
 |  BC Extra  |  Company News

OcellO, Merus in cancer antibodies screening deal

OcellO B.V. (Leiden, the Netherlands) partnered with Merus B.V. (Utrecht, the Netherlands) to screen human bispecific antibodies from Merus -- called Biclonics...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >